Skip to main content
. 2014 Sep 9;8:1307–1314. doi: 10.2147/DDDT.S68542

Table 4.

Laboratory and clinical characteristics

Characteristics (all parameters), mean ± SD CSA group TAC group P-value
Creatinine (mg/dL)
 Baseline 1.1±0.5 1.5±0.8 <0.0001
 2 years after HTX 1.4±0.4a 1.7±1.3b ns
MDRD (mL/min*1.73 m2)
 Baseline 82.4±34.2 67.6±40.7 0.0030
 2 years after HTX 61.3±25.0a 57.6±24.9a ns
Sodium (mmol/L)
 Baseline 136.5±3.8 137.5±3.4 0.0428
 2 years after HTX 138.6±3.5a 139.2±2.8a ns
Potassium (mmol/L)
 Baseline 4.2±0.5 4.3±0.6 ns
 2 years after HTX 4.3±0.4b 4.4±0.5b ns
Serum urea (mg/dL)
 Baseline 69.7±45.3 78.6±41.4 ns
 2 years after HTX 56.8±20.1a 57.3±25.8b ns
Uric acid (mg/dL)
 Baseline 5.9±2.3 6.8±2.6 0.0075
 2 years after HTX 6.6±1.9a 6.8±2.2b ns
Blood glucose trough level (mg/dL)
 Baseline 117.2±49.7 127.0±56.4 ns
 2 years after HTX 109.2±30.2b 114.0±37.0b ns
Creatine phosphokinase (U/L)
 Baseline 23.3±23.3 35.9±21.8 <0.0001
 2 years after HTX 141.0±157.3a 150.8±142.9a ns
ASAT (U/L)
 Baseline 17.3±10.7 24.2±16.7 0.0007
 2 years after HTX 16.4±8.3b 29.8±32.8b 0.0014
ALAT (U/L)
 Baseline 35.7±31.3 49.0±36.7 0.0048
 2 years after HTX 17.6±13.6a 24.3±15.2a 0.0061
GGT (U/L)
 Baseline 111.7±112.0 306.4±271.1 <0.0001
 2 years after HTX 30.6±29.7a 83.3±99.4a <0.0001
Total blood cholesterol level (mg/dL)
 Baseline 220.5±56.6 198.0±50.1 0.0021
 2 years after HTX 193.7±46.6a 178.1±35.5a 0.0252
HDL (mg/dL)
 Baseline 60.3±22.5 61.4±20.6 ns
 2 years after HTX 48.7±15.6a 50.1±16.3a ns
LDL (mg/dL)
 Baseline 128.9±48.1 104.2±32.4 0.0002
 2 years after HTX 114.0±30.5a 95.8±31.4b 0.0006
Triglycerides (mg/dL)
 Baseline 184.5±95.5 183.1±78.2 ns
 2 years after HTX 163.2±135.5b 158.8±84.2a ns
Lactate dehydrogenase (U/L)
 Baseline 282.9±109.3 297.0±104.9 ns
 2 years after HTX 196.9±86.8a 252.3±76.1a 0.0002
Alkaline phosphatase (U/L)
 Baseline 149.3±96.9 145.1±114.4 ns
 2 years after HTX 106.6±58.9b 95.9±54.8a ns
Hemoglobin (g/dL)
 Baseline 11.4±1.3 11.0±1.2 0.0080
 2 years after HTX 12.7±1.6a 12.8±1.8a ns
Thrombocytes (/nL)
 Baseline 273.3±129.0 314.7±136.1 0.0189
 2 years after HTX 244.3±66.5b 215.8±67.3a 0.0109
Leukocytes (/nL)
 Baseline 10.0±5.2 10.1±4.5 ns
 2 years after HTX 6.7±2.0a 6.3±2.0a ns
Systolic blood pressure (mmHg)
 Baseline 125.5±14.3 120.8±17.5 0.0317
 2 years after HTX 126.2±15.8b 121.1±14.4b 0.0405
Diastolic blood pressure (mmHg)
 Baseline 77.0±9.6 73.1±11.20 0.0060
 2 years after HTX 77.2±9.6b 75.4±10.6b ns

Notes:

a

P<0.05 vs baseline, statistically significant

b

P<0.05 vs baseline, ns.

Abbreviations: ALAT, alanine aminotransferase; ASAT, aspartate aminotransferase; CSA, cyclosporine A; GGT, gamma-glutamyl transferase; HDL, high-density lipoprotein; HTX, heart transplantation; LDL, low-density lipoprotein; MDRD, Modification of Diet in Renal Disease; ns, not statistically significant; SD, standard deviation; TAC, tacrolimus.